pyrazinamide has been researched along with Inflammation in 3 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Excerpt | Relevance | Reference |
---|---|---|
"Pyrazinamide (PZA) is an essential antitubercular drug, but little is still known about its hepatotoxicity potential." | 5.43 | Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae. ( Chen, W; Ding, P; Guo, H; Han, L; Hassan, HM; He, Q; Hsiao, CD; Jiang, Z; Liu, K; Zhang, L; Zhang, Y, 2016) |
"Pyrazinamide (PZA) is an essential antitubercular drug, but little is still known about its hepatotoxicity potential." | 1.43 | Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae. ( Chen, W; Ding, P; Guo, H; Han, L; Hassan, HM; He, Q; Hsiao, CD; Jiang, Z; Liu, K; Zhang, L; Zhang, Y, 2016) |
"Seventy-five male patients with pulmonary tuberculosis (mean age, 40." | 1.40 | Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment. ( de Melo Guedes de Oliveira, HM; de Oliveira, MM; Delogo, KN; Dos Anjos, MJ; Kritski, AL; Mesquita, ED; Miranda, PF; Moraes, ML; Netto, AR; Ramalho, DM, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saunders, MJ | 1 |
Edwards, BS | 1 |
Zhu, J | 1 |
Sklar, LA | 1 |
Graves, SW | 1 |
Moraes, ML | 1 |
Ramalho, DM | 1 |
Delogo, KN | 1 |
Miranda, PF | 1 |
Mesquita, ED | 1 |
de Melo Guedes de Oliveira, HM | 1 |
Netto, AR | 1 |
Dos Anjos, MJ | 1 |
Kritski, AL | 1 |
de Oliveira, MM | 1 |
Zhang, Y | 1 |
Liu, K | 1 |
Hassan, HM | 1 |
Guo, H | 1 |
Ding, P | 1 |
Han, L | 1 |
He, Q | 1 |
Chen, W | 1 |
Hsiao, CD | 1 |
Zhang, L | 1 |
Jiang, Z | 1 |
3 other studies available for pyrazinamide and Inflammation
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Topics: Adult; Antitubercular Agents; Biomarkers; C-Reactive Protein; Copper; Ethambutol; Hemoglobins; Host- | 2014 |
Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.
Topics: Animals; Animals, Genetically Modified; Antitubercular Agents; Apoptosis; Fatty Acid-Binding Protein | 2016 |